|Home | About | Journals | Submit | Contact Us | Français|
Elevated oxidative stress is closely associated with obesity. Emerging evidence shows that instead of being a consequence of obesity, oxidative stress may also contribute to fat formation. Nonselenocysteine-containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) is a conserved oxidative stress sensor/transducer and deficiency of NPGPx causes accumulation of reactive oxygen species (ROS). In this communication, we show that NPGPx was highly expressed in preadipocytes of adipose tissue. Deficiency of NPGPx promoted preadipocytes to differentiate to adipocytes via ROS-dependent dimerization of protein kinase A regulatory subunits and activation of CCAAT/enhancer-binding protein beta (C/EBPβ). This enhanced adipogenesis was alleviated by antioxidant N-acetylcysteine (NAC). Consistently, NPGPx-deficient mice exhibited markedly increased fat mass and adipocyte hypertrophy, while treatment with NAC ablated these phenotypes. Furthermore, single nucleotide polymorphisms (SNPs) in human NPGPx gene, which correlated with lower NPGPx expression level in adipose tissue, were associated with higher body mass index (BMI) in several independent human populations. These results indicate that NPGPx protects against fat accumulation in mice and human via modulating ROS, and highlight the importance of targeting redox homeostasis in obesity management.
Deficiency of the glutathione peroxidase NPGPx increases ROS levels in preadipocytes and promotes adipocyte differentiation via increasing oxidative stress and consequent increased fat mass and adipocyte hypertrophy.
Obesity is a global epidemic with huge impact on human health. Epidemiological studies have consistently observed a close association between oxidative stress and excessive fat accumulation (Festa et al, 2001; Keaney et al, 2003; Urakawa et al, 2003). Although the causal relationship underlying this association remained uncertain, fat accumulation with subsequent inflammatory response was generally considered as the sources of oxidative stress (Furukawa et al, 2004; Weisberg et al, 2003). However, emerging evidence suggests that instead of being a consequence, oxidative stress may be a prerequisite for adipogenesis. Reactive oxygen species (ROS) level is increased during adipogenesis (Tormos et al, 2011). Administration of mitochondria-targeted antioxidants reduces adipocyte differentiation while exogenous H2O2 promotes adipocyte differentiation in mesenchymal stem cells (Tormos et al, 2011). Nevertheless, the physiological relevance of these observations have not been tested in vivo and the how ROS is regulated during normal adipocyte differentiation is little known.
Several physiological processes including mitochondrial oxidative phosphorylation and protein folding at the endoplasmic reticulum (ER) generate superoxide (O-2). Superoxide is first converted to H2O2 by superoxide dismutase and then to water by antioxidant enzymes such as catalase, thioredoxin peroxidase, and glutathione peroxidase (GPx) (D'Autreaux & Toledano, 2007). Among them, the GPx represent an important protein family discovered in nearly all kingdoms of life. To date, eight homologous GPx members (GPx1–8) have been identified in mammals (Toppo et al, 2008). GPx1 is ubiquitously distributed. However, GPx1 knockout mice develop normally without evidence of increased oxidative stress (Ho et al, 1997). GPx2 (gastrointestinal GPx) is expressed mainly in the gastrointestinal epithelium (Chu et al, 1993). GPx3 (plasma GPx) is an extracellular enzyme secreted from the kidney into the circulating blood (Yoshimura et al, 1991). GPx5 is a selenocysteine-independent GPx expressed specifically in the epididymis (Chabory et al, 2009) and GPx6 is found almost exclusively in the olfactory epithelium. In contrast to GPx1, 2, 3, 5 and 6 which appeared relatively recently in evolution, phylogenic analysis revealed that GPx4, 7 and 8 are ancient with conserved sequences in protozoa and invertebrate (Toppo et al, 2008). GPx4 (phospholipid hydroperoxide GPx) is a membrane-bound protein that accepts phospholipid hydroperoxides in membranes as substrates with important function in spermatogenesis (Imai et al, 2009). GPx7, also known as nonselenocysteine-containing phospholipid hydroperoxide glutathione peroxidase (NPGPx, Gene ID: 67305), and GPx8 share a similar structure but without glutathione-binding domain and have no apparent enzymatic activity (Nguyen et al, 2011). NPGPx was identified as an oxidative stress sensor/transducer that senses and transmits cellular ROS to downstream mediators to reduce ROS accumulation (Nguyen et al, 2011; Peng et al, 2012; Utomo et al, 2004; Wei et al, 2012), while the biological function of GPx8 remains to be shown. In contrast to GPx1 knockout mice, which have little obvious phenotype, loss of NPGPx increases oxidative stress in mice (Wei et al, 2012), suggesting NPGPx is essential for maintaining redox homeostasis.
In this communication, we show that NPGPx was highly expressed in preadipocytes but not in mature adipocytes. Deficiency of NPGPx facilitated preadipocytes to differentiate to adipocytes through ROS-dependent activation of PKA/C/EBPβ signalling pathway. Consistently, NPGPx-deficient mice exhibited increased white fat mass and adipocyte hypertrophy that can be prevented by antioxidant N-acetylcysteine (NAC). Furthermore, single nucleotide genetic polymorphisms near the human NPGPx gene, which correlated with lower NPGPx expression in white adipose tissue, were associated with increased adiposity in several independent human populations. These results indicate that NPGPx plays a critical role in adiposity mediated through redox homeostasis.
To investigate the physiological role of NPGPx, we first compared the tissue expression patterns of GPx gene family. Among all GPx members, NPGPx was highly enriched in white adipose tissue (Supporting Information Fig S1A–I). Within white adipose tissue, NPGPx was mainly expressed in the stromal vascular fraction (SVF), specifically in preadipocytes, but little in mature adipocytes, macrophages or endothelial cells (Fig 1A, B). Expression of NPGPx in 3T3-L1 preadipocytes declined rapidly within the first 24h during the course of induced adipocyte differentiation, followed by the rise of C/EBPβ and peroxisome proliferator-activated receptor gamma (PPARγ) (Fig 1C, D). These expression profiles implicated that NPGPx may have a role in adipogenesis.
To test this possibility, SVF cells isolated from white adipose tissue of NPGPx knockout or wild-type mice were induced for adipocyte differentiation by hormonal stimulation. Throughout the differentiation course, SVF cells from NPGPx knockout mice showed consistently higher ROS levels, as measured by nitroblue tetrazolium (NBT) reduction staining (Fig 1E) and were more prone to differentiate into adipocytes (Fig 1F) than that of wild-type mice with higher expression of adipogenic marker genes including ap2 and adiponectin (Fig 1G). Ectopic re-expression of human NPGPx gene in SVF cells from knockout mice suppressed ROS levels (Fig 1E) and reduced differentiation ability (Fig 1F, G) (Supporting Information Fig S2A). Similarly, knockdown of NPGPx in 3T3-L1 preadipocytes increased ROS levels (Fig 1H) and enhanced adipogenesis (Fig 1I) (Supporting Information Fig S2B), while ectopic overexpression of NPGPx in 3T3-L1 cells reduced ROS levels (Supporting Information Fig S3A, B) and suppressed adipogenesis (Supporting Information Fig S3C, D). Consistently, both primary SVF cells and adipocytes isolated from white adipose tissue of NPGPx knockout mice displayed significantly higher ROS levels than those from wild-type littermates (Supporting Information Fig S4A). These findings indicate that NPGPx deficiency elevates ROS level and enhances adipocyte differentiation.
To test whether the pro-adipogenic effect resulting from NPGPx deficiency is mediated by the increased ROS, we thought to use antioxidants or pro-oxidants to assay the effect on adipogenesis. The ROS level and differentiation ability were higher in NPGPx-knockdown 3T3-L1 cells than in control cells in response to different dose of NAC treatment (Fig 1K, L). Quantitative measurements indicated that the ROS levels correlated strongly (r=0.96, p<0.0001) with the degree of adipocyte differentiation for various doses of NAC (Fig 1 M). Similar suppressive effects were observed using tiron, a superoxide scavenger (Han & Park, 2009) and 4-phenylbutyrate (PBA), a chemical chaperone that reduces ROS levels (Liu et al, 2002) (Supporting Information Fig S4B, C). In contrast, adding different dose of H2O2 during the differentiation course, the NPGPx-knockdown 3T3-L1 cells appeared to be more differentiated than the control cells (Fig 1N). These data indicate that NPGPx participates in adipogenesis through modulating cellular ROS level.
To explore the molecular mechanism by which ROS enhances adipogenesis, we assessed the expression of key transcriptional factors involved in adipocyte differentiation (Yeh et al, 1995). C/EBPβmRNA expression was significantly increased in NPGPx-knockdown 3T3-L1 preadipocytes after adipogenic induction (Fig 2A). Expression of downstream transcriptional factors including C/EBPα and PPARγ mRNA was also higher in NPGPx-knockdown cells (Fig 2A). These results indicate NPGPx deficiency in 3T3-L1 preadipocytes increases the expression of key transcription factors involved in adipogenesis.
C/EBPβ expression is primarily regulated through the PKA/CREB signalling pathway (Rosen & MacDougald, 2006). PKA is a hetero-tetramer comprising of 2 regulatory subunits harbouring potential ROS-sensitive cysteinyl residues and 2 catalytic subunits (Brennan et al, 2004; Weerapana et al, 2010). After adipogenic hormonal stimulation, cAMP binds to the PKA regulatory subunit, causing the breakdown of the PKA complex and the release of the PKA catalytic subunit. The PKA catalytic subunits phosphorylate cyclic AMP response element-binding protein (CREB), which in turn binds to the promoter of C/EBP β. Therefore, we tested whether NPGPx depletion affect the key steps of this cascade. We found that NPGPx deficiency promoted the dimerization of PKA regulatory subunits (Fig 2B), the release of the monomeric PKA catalytic subunits (Fig 2C) and the CREB phosphorylation (Fig 2D). Antioxidant NAC treatment suppressed the dimerization of PKA regulatory subunits and the CREB phosphorylation (Fig 2E), leading to the reduction of C/EBP β expression (Fig 2F). These data indicate that NPGPx deficiency increases C/EBP β expression through PKA signalling pathway in an ROS-dependent manner.
It has been reported that C/EBPβ is activated by ROS to form a dimer through the formation of intermolecular disulphide bonds. This conformational change increases its DNA binding activity (Tang & Lane, 2012). We then tested whether NPGPx deficiency has any effect on C/EBP β dimerization and its DNA binding activity. As shown in Fig 3A, B, the expression of C/EBPβ monomer and dimer peaked at 12h after adipogenic induction and declined afterwards in control cells. In contrast, the expression of C/EBPβ monomer and dimer persisted beyond 24h in NPGPx-deficient cells. In addition, the dimer to monomer ratio of C/EBPβ was also increased in NPGPx-deficient cells (Fig 3A). The increased dimerization of C/EBPβ was associated with increased DNA binding to the promoter of C/EBPα (Fig 3C) and increased expression of downstream C/EBPα and PPARγ (Fig 3D). Treatment with NAC reduced the dimerization (Fig 3E) and DNA binding activity of C/EBP β (Fig 3C), and suppressed the expression of C/EBPα and PPARγ (Fig 3D).
In addition to transcriptional activation of the adipogenic cascade, C/EBPβ is also required for mitotic clonal expansion in early adipogenesis (Tang et al, 2003). We then tested this possibility by measuring cell proliferation in early adipogenesis and found an increase of proliferation in NPGPx-knockdown cells after induction, which was suppressed by NAC (Supporting Information Fig S5). The increased mitosis in early adipocyte differentiation explains the increased cellular proliferation found in NPGPx knockout mice.
To affirm that C/EBPβ is responsible for the pro-adipogenic effect resulting from NPGPx deficiency, we compared the effect of NPGPx on adipogenesis in the presence or absence of C/EBP β. We found that the pro-adipogenic effect conferred by NPGPx deficiency was abolished when C/EBPβ was absent (Fig 3F–H), indicating that C/EBPβ is essential for mediating the pro-adipogenic effect resulting from NPGPx deficiency. Taken together, these data suggested that NPGPx deficiency increases both the expression and dimerization of C/EBP β through a ROS-mediated mechanism, thereby enhancing adipocyte differentiation.
Next, we sought to determine whether NPGPx affects adipogenesis in vivo. On standard chow diet containing 13% calories from fat, the body weight of NPGPx knockout mice was not different from those of wild-type littermates (Fig 4A). However, when mice were fed the high-fat diet (HFD) containing 60% calorie from fat, the mutant mice became significantly heavier than wild-type littermates (Fig 4A, B). Micro-computed tomography (CT) revealed higher body fat percentages of NPGPx knockout mice compared to wild-type littermates on HFD (Fig 4C). White fat pads, including inguinal, gonadal and mesenteric fat, were substantially increased (~2-fold) in knockout mice (Fig 4D). Histological examination revealed that the adipocyte size (adipocyte hypertrophy) (Fig 4E, F) and, to a lesser extent, the adipocyte number (adipocyte hyperplasia) was increased in the gonadal fat of knockout mice on an HFD (Fig 4G), accompanied with an increased expression of adipogenic marker genes such as pparg, ap2, cd36/fat and aqp7 (Fig 4H). Increased cell proliferation measured by bromodeoxyuridine (BrdU) uptake was observed in the gonadal fat tissue of knockout mice on HFD (Supporting Information Fig S6). These data indicate that NPGPx deficiency facilitated cell proliferation and hyperplasia in fat tissue of mice. The increased adiposity was associated with elevated fasting plasma free fatty acids (Fig 4I), triglycerides (Fig 4J) and insulin levels (Fig 4K). Fasting glucose was not changed (Fig 4K). Increased macrophage infiltration with higher expression of inflammatory marker genes (tnfα, il6 and il1β) was also observed in fat tissue of these mice (Supporting Information Fig S7).
No difference in food intake (Supporting Information Fig S8A) between knockout and wild-type mice was noted. Reduced energy expenditure was observed in knockout mice during the dark/active phase as compared to wild-type mice on HFD, whereas no difference was observed on chow diet (Supporting Information Fig S8B). Spontaneous ambulatory activity was also decreased in knockout mice on HFD but not in chow diet (Supporting Information S9A). However, exercise capability assayed by exercise endurance test or rotarod test was not impaired in these mice (Supporting Information Fig S9B, C). We cannot detect defect of fatty acid beta-oxidation (Supporting Information Fig S9D) and mitochondrial oxidative phosphorylation (Supporting Information Fig S9E) in primary myoblasts or fibroblasts isolated from NPGPx knockout mice. Furthermore, rectal temperature and expression of genes involved in thermogenesis in brown adipose tissue (BAT) were not altered in knockout mice (Supporting Information Fig S9F, G).
To test whether anti-oxidant NAC can reduce adiposity in NPGPx-deficient mice, mice were given either regular drinking water or water supplemented with NAC. NAC treatment suppressed fat accumulation and reduced ROS levels in both mutant and wild-type mice on HFD (Fig 5A–C). The differences in ROS levels and fat accumulation between mutant and wild-type mice were completely mitigated by the NAC treatment (Fig 5A–C), as were differences in body fat percentage, fat pad weights and adipocyte size (Fig 5D–F). Similar effects were also found for fasting plasma free fatty acids (Fig 5G), triglycerides (Fig 5H) and insulin (Fig 5I) levels. Fasting glucose level was not changed (Fig 5I). NAC treatment did not alter food intake (Supporting Information Fig S10A) or energy expenditure in either mutant or wild-type mice (Supporting Information Fig S10B).
To test whether NPGPx also plays a role in human adiposity, we analysed the association of single nucleotide polymorphisms (SNPs) near the human NPGPx gene with adiposity in independent human populations. The genetic variant rs835337, which was located upstream the human NPGPx gene (Fig 6A), was significantly associated with the BMI in 1424 adults of the British 1958 Birth Cohort (Fig 6C, p=0.005, Supporting Information Table S1) and 4758 adults in the North Finland Birth Cohort (Fig 6B, p=0.03, Supporting Information Table S1). This variant was also associated with BMI in 760 Han Chinese adults (Fig 6D, p=0.006 in dominant genetic model, corrected p=0.007 for multiple genetic models, Supporting Information Table S1). Meta-analysis pooling these three independent studies showed a significant association between rs835337 and BMI (p=0.0004) (Supporting Information Fig S11A). This SNP is located within a large linkage disequilibrium (LD) block spanning the entire NPGPx gene. Other SNPs in strong LD with rs835337, including rs7529595 and rs6588432 downstream of the NPGPx gene, were also associated with BMI (p=0.002 and 0.0003, respectively) (Supporting Information Fig S11B, C and Table S1). Importantly, the risk-conferring G allele of rs835337 was associated with lower NPGPx gene expression in abdominal fat depots (Fig 6E) and higher plasma malondialdehyde levels, an oxidative stress marker in human (Fig 6F). Taken together, these results suggest that the subjects carrying risk NPGPx alleles may have reduced NPGPx expression in adipose tissue and higher BMI.
NPGPx is an ER-resident oxidative stress transducer that transmits oxidative stress to downstream effecters, thereby alleviating cellular ROS (Nguyen et al, 2011; Peng et al, 2012; Utomo et al, 2004; Wei et al, 2012). Among all GPx member, NPGPx was mainly expressed in white adipose tissue. Depletion of NPGPx increased adipogenesis both in vitro and in vivo through ROS-dependent modulation of early transcriptional cascade for adipocyte differentiation. The increased ROS caused by NPGPx deficiency facilitated the dimerization of PKA regulatory subunits, leading to increased released of the PKA catalytic subunits and enhanced downstream signalling to activate C/EBPβ transcription.
It is of note that both the monomer and dimer forms of C/EBPβ were persistently higher in NPGPx-deficient cells after adipogenic stimulation. This can be attributed to the enhanced C/EBPβ transcription at the earlier time point. In addition, the ratio of C/EBPβ dimer to monomer was also increased in NPGPx-deficient cells during adipocyte differentiation. ROS is required for the disulphide bond formation between the leucine zipper regions of C/EBPβ to form a dimer, which the basic regions of two C/EBPβ monomers are brought together to create a ‘scissors-like’ DNA binding pocket to facilitate DNA binding (Kim et al, 2007). In NPGPx-deficient preadipocytes, increased ROS shifted the monomer-dimer equilibrium to dimer formation of C/EBPβ and hence facilitated adipocyte differentiation. Since many lipogenic enzymes such as fatty acid synthase, pyruvate kinase or ATP-citrate lyase have also been reported to harbour potential redox-sensitive cysteinyl residues (Weerapana et al, 2010; Ziegler, 1985), whether the increased ROS in NPGPx-deficient cells also modifies these downstream lipogenic enzymes to affect adipogenesis remains to be explored.
Cellular ROS is mainly generated from ER and mitochondria. It was reported that elevated ROS from mitochondria due to the loss of peroxiredoxin 3, a mitochondria-specific peroxidase, promoted fat accumulation in mice (Huh et al, 2012). This is consistent with our finding that deficiency of NPGPx, an ER-resident oxidative stress sensor/transducer, increases ROS and facilitates adipocyte differentiation as described herein. These results indicate that ROS either generated from ER or mitochondria may have an important role for adipocyte differentiation.
In addition to the activation of downstream lipogenic transcriptional cascade for terminal differentiation of adipocytes, C/EBPβ has a critical role for mitotic clonal expansion in early adipogenesis (Rosen & MacDougald, 2006; Tang et al, 2003). Consistently, in NPGPx-deficient cells, both mitotic clonal expansion in early adipogenesis and PPARγ expression in late differentiation were increased upon C/EBPβ activation. Similarly, increased cellular proliferation and PPARγ expression were also observed in adipose tissue in NPGPx knockout mice. These data indicate NPGPx deficiency promotes both adipocyte proliferation and hypertrophy.
Obesity results from the complex interaction between food intake, energy expenditure, and the tendency to deposit energy (so-called nutrient partitioning) (O'Rahilly, 2009). Although food intake was similar between NPGPx knockout and wild-type mice, energy expenditure in the dark/active phase and spontaneous ambulatory activity was reduced in knockout mice as compared to wild-type mice on HFD but not on chow. However, exercise capability was not impaired in these mice and we cannot detect any defect of mitochondrial oxidative phosphorylation, fatty acid oxidation or thermogenesis in these mice. Instead, a strong tendency to deposit energy as fat (i.e. enhanced adipogenesis potential) was observed in NPGPx knockout mice. These results suggest the obesity phenotype in NPGPx knockout mice was likely due to the enhanced adipogenesis.
The cause underlying the lower energy expenditure and spontaneous ambulatory activity in NPGPx knockout mice remained to be resolved. It is likely that adaptive changes of energy expenditure and spontaneous ambulatory activity may occur with increased adiposity. Interestingly, increased activity and energy expenditure was also observed in adipose-specific PPARγ knockout mice, which exhibited marked loss of fat mass and resistance to HFD-induced obesity due to defective adipogenesis (Jones et al, 2005), suggesting energy balance and activity level may be changed with altered adiposity. Alternatively, NPGPx deficiency may directly down-regulate energy expenditure through unknown mechanism, leading to the obesity. Future studies using tissue-specific NPGPx knockout mice will further strengthen this concept.
Interestingly, the NPGPx gene was previously mapped within a candidate quantitative locus for BMI (p=0.009) by a genome-wide linkage analysis in human (Platte et al, 2003). A quantitative trait loci mapping for body weight in rats also identified a candidate region harbouring the npgpx gene (p=0.01, LOD=3.1) (Seda et al, 2005). We found that genetic variations near the NPGPx gene were associated with BMI in several independent human populations. These genetic variants are in strong LD with each other and rs835337 is the tagSNP for other SNPs at r2 of 0.8. The study-wide significance level that takes into account of the LD among SNPs was estimated to be 0.039 after correction of multiple markers (Nyholt, 2004). Nearly all p-values are lower than this threshold. Furthermore, a modest association of rs835337 and rs7529595 with BMI in the same direction was also found (p=0.01 and 0.01, respectively) in the GIANT Consortium, a large meta-analysis of genome-wide association studies (GWASs) comprising 249,796 subjects (Speliotes et al, 2010). These data support a role of NPGPx in modulating BMI. Although how these SNPs in NPGPx gene affect BMI is currently unclear, the correlation between rs835337 genotype and NPGPx mRNA levels in human adipose tissue implicates that the functional variant may be involved in the regulation of NPGPx gene expression.
Importantly, the finding of the potent anti-adipogenic activity of NAC is particularly worth mentioning. NAC is a precursor of cysteine and can be converted intracellularly to the reduced form of glutathione and has been approved for the treatment of acetaminophen-induced hepatic injury and prevention of radiocontrast-induced nephropathy due to its potent anti-oxidant property (Heard, 2008; Marenzi et al, 2006). Our results clearly demonstrated that NAC effectively prevented fat accumulation through ROS scavenging (Fig 5). The mechanism by which NAC prevent adipogenesis in vivo was not fully elucidated. Previous studies proposed ROS suppresses food intake through modulation of hypothalamic melanocortin system and intracerebroventricular injection of ROS scavenger increased food intake (Diano et al, 2011). Our study, however, did not find significant effect of NAC on food intake. Specifically, NAC have no effect on weight in chow-fed mutant or wild-type mice, indicating limited drug toxicity. Interestingly, bardoxolone methyl, a novel antioxidant activating the Keap1-Nrf2 pathway, also showed unexpected weight-reducing effects in a recent clinical trial (Pergola et al, 2011). Similarly, alpha-lipoic acid, an ROS scavenger for hydroxyl radicals and singlet oxygen (Packer et al, 1995), exerts reproducible anti-obesity effects in several independent clinical trials (Carbonelli et al, 2010; Kim et al, 2008; Koh et al, 2011). The anti-adipogenic effect of NAC, an established and approved drug with a good safety profile, provides a new therapeutic opportunity for the prevention of obesity.
To generate NPGPx knockout mice, a gene-targeting strategy was used as previous described (Wei et al, 2012). To obtain homozygous litters, offspring with germline-transmitted targeted gene were obtained by backcrossing chimera mice to C57BL/6. NPGPx knockout (NPGPx−/−) mice and wild-type littermate (NPGPx+/+) were generated by heterozygous mating. Unless otherwise indicated, the mice used in these experiments were female. For gene expression profiling in epididymis, male mice were used.
All mice were housed at 23°C and light/dark cycles of 12/12h. All animal experiments were performed according to national ethical guidelines and were approved by the local animal experimentation committee of the Academia Sinica, Taiwan. Mice were fed ad libitum with a standard mouse chow diet (13% calorie from fat, TestDiet 5010) or HFD (60% calorie from fat, TestDiet 58Y1). For the NAC (Sigma A7250) treatment, NAC was added to drinking water at a concentration of 2mg/1mL and was renewed twice weekly.
CT images were acquired using a microCT instrument (FLEX Triumph, General Electric) with mice under anaesthesia by inhalation of isofluorane in oxygen. The analysis of body fat mass was performed using the Amira software (Visage Imaging GmbH). Region of interest (ROI) comprising the trunk of mice was selected and the body fat was defined by a Hounsfield unit between −250 and −50.
Mice were measured at the age of 18 weeks using an 8-chamber LabMaster Calorimetry Module (TSE-Systems GmbH) with one mouse per chamber. After acclimatization individually for 72h, the O2 consumption (VO2, mL/kg/min), CO2 production (VCO2, mL/kg/min), and respiratory quotient (ratio of VCO2/VO2) were determined. VO2 and VCO2 were recorded every 30min for a total of 48h. The energy expenditure was calculated as the product of the calorific value of oxygen (3.815+1.232×respiratory quotient) and VO2. To measure the food intake, mice were housed in metabolic cages for 72h, and food and water intake were measured during the final 48h.
Retro-orbital blood was collected after fasting for 6h in mice at the age of 24 weeks under anaesthesia by inhalation of isofluorane in oxygen. Plasma triglyceride was quantified by the Fuji Dri-Chem Clinical Chemistry Analyzer. Plasma free fatty acids were measured using colorimetric assays (Wako 294-63601).
Four week-old female mice were euthanized by CO2 inhalation, and inguinal fat pads were collected, minced and digested with type I collagenase at 37°C in a shaking water bath for 60min. The digested fat was filtered through a sterile 70µm nylon mesh to remove undigested fragments. The filtered suspension was centrifuged at 300g for 10min. Floating cells and the cell pellet were recovered as the mature adipocyte fraction and the SVF, respectively. Each fraction was washed twice with PBS. The SVF was incubated in erythrocytes lysis buffer (155mM NH4Cl, 10mM KHCO3 and 0.1mM EDTA) for 10min, centrifuged to pellet and washed with PBS. The SVF was then cultured in Dulbecco's modified Eagle medium (DMEM) Nutrient Mixture F-12 (Invitrogen 11320-033) with 5% fetal bovine serum (FBS). When the cells reached confluence, differentiation was induced by adding adipogenic differentiation medium.
For ROS measurement, primary SVF and adipocytes isolated from gonadal fat pads were incubated with CM-H2-DCFDA (5µM) (Molecular Probe C6827, Invitrogen) in phenol-free DMEM. CM-H2-DCFDA is an ester probe that reacts with intracellular ROS and the oxidative adduct of CM-H2-DCFDA emits green florescence upon excitation. After 60min of incubation, cells were analysed by FACS Canto II instrument (BD Biosciences) using excitation at 485nm and emission at 530nm. The mean fluorescence intensity was used to estimate cellular ROS levels.
Gonadal fat pads were stored in liquid nitrogen immediately after harvest. Fat pads (about 100mg) were homogenized in 1mL of PBS, sonicated, and centrifugated in 4°C to removed debris and floating lipid. The ROS amount of homogenate was determined using commercial kit (Cell Biolabs STA347) according to manufacturer's instruction. Briefly, the quenched DCF-DiOxyQ probe was primed to DCF-DiOxy and then converted to the non-fluorescent DCFH probe. DCFH can react with ROS to form fluorescent DCF. Tissue homogenate was then incubated with DCFH and catalytic agents. The fluorescence intensity was analysed using excitation at 485nm and emission at 530nm and was normalized to the total protein content of tissue homogenates.
Small hairpin RNA (shRNA) plasmids for the mouse NPGPx gene and the empty control vector (pLKO_TRC014) were obtained from the National RNAi Core Facility (Academia Sinica, Taiwan) and the target sequences for mouse NPGPx was 5′-CCTTCGGAAACGAGAAGACTT-3′. Human NPGPx cDNA was inserted in lentiviral vectors (pLKO-AS2) containing a hygromycin selection marker. Lentivirus production and infection of cells were performed following the procedures of the National RNAi Core Facility.
Intracellular ROS level was determined by the NBT reduction assay. Cells were harvested at the times indicated and incubated with 0.2% NBT (Sigma N6876) for 90min. After incubation, the reduced NBT was dissolved in 50% acetic acid and the absorbance was determined at 560nm.
Nuclear protein from differentiated 3T3-L1 cells were extracted using the ProteoJET Cytoplasmic and Nuclear Protein Extraction Kit (ThermoFisher Scientific 0311) and EMSA was performed using the LightShift Chemiluminescent EMSA Kit (Pierce 20148). The nuclear extract was incubated for 30min at room temperature with a biotinylated oligonucleotide containing the C/EBP β binding site of the C/EBPα promoter 5′-GCGTTGCGCCACGATCTCTC-3′. For competition experiments, nuclear extracts were incubated with an unlabelled competitor oligonucleotide (100-fold molar excess) for 15min before the addition of the biotin-labelled probe. After the binding reaction, the mixture was separated electrophoretically on a 6% polyacrylamide gel in 0.5×TBE and was then transferred to nylon membrane. The biotinylated oligonucleotide probe was detected by chemiluminescence using the Chemiluminescent Nucleic Acid Detection Module (Pierce 89880).
For haematoxylin and eosin (HE) staining, white adipose tissues was fixed in 4% paraformaldehyde, processed and embedded in paraffin before sectioning and staining. Two sections were obtained for each mouse. The stained sections were scanned and analysed using MIRAX Viewer (http://www.zeiss.de/mirax) and Image J software (http://rsbwed.nih.gov/ij/). For adipocyte size measurements, 200 consecutive fat cells of the gonadal fat pad from each mouse were selected for the area measurement. The adipocyte number of the gonadal fat pad was calculated as the fat pad volume divided by the average fat cell volume. Fat pad volume was calculated as fat pad weight (g) divided by fat density (0.915g/cm3).
The quantification of cell proliferation was performed using a commercial kit (Roche 11669915001). 3T3-L1 cells were treated with induction medium for 18h with or without NAC and were labelled with bromodeoxyuridine (BrdU). Cells were then fixed, stained with anti-BrdU antibody and visualized using a chemiluminescent immunoassay.
Total protein from cells was extracted with RIPA buffer [50mM Tris–HCl, pH 7.4, 150mM NaCl, 2mM ethylenediaminetetraacetic acid (EDTA), 50mM NaF, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS) and 1mM phenylmethylsulphonyl fluoride (PMSF)] for 5min, sonicated, and centrifuged to removed debris. For reducing SDS-polyacrylamide gel electrophoresis, the protein sample was mixed with SDS sample buffer (containing dithiothreitol, DTT) and denatured by boiling for 5min. For non-reducing SDS-polyacrylamide gel electrophoresis, the protein sample was reconstituted in non-reducing SDS sample buffer (without DTT). Primary antibodies targeted NPGPx (ProteinTech 13501), aP2 (R&D AF1443), adiponectin (Biovision 5900), α-tubulin (GeneTex 11302), GAPDH (GeneTex 627408), C/EBPβ (BioLegend 606201), PKA C-α (Cell Signalling 4782), PKA-RI-α (Cell Signalling 5675), phospho-CREB (Millipore 05-667) and CREB (Cell Signalling 9104) was used.
The 3T3-L1 preadipocytes were cultured in high-glucose DMEM (Invitrogen 11965) with 10% calf serum at 37°C in an atmosphere of 5% CO2. Post-confluent cells were induced by adipogenic differentiation medium containing high-glucose DMEM, 10% FBS (GibcoBRL 16170), 1µM dexamethasone (Sigma D4902), 0.5mM isobutylmethylxanthine (Sigma I7018) and 5µg/mL of bovine insulin (Sigma I5500). After 2 days, the cells were maintained in high-glucose DMEM containing 10% FBS and 5µg/mL of bovine insulin. After another 2 days, medium was changed to high-glucose DMEM containing 10% FBS until the day 8 harvest. Cells were stained with Oil Red O (Sigma O0625) to measure the degree of adipocyte differentiation. To assess the effect of NAC, tiron (Sigma 89460) or PBA (Merck4Bioscineces 567616) on adipocyte differentiation, these reagents were added at the first 2 days after the induction with the indicated concentration, respectively. For NAC effect on PKA regulatory subunit dimerization, cells were pretreated with NAC for 24h.
Total RNA was extracted from respective tissues or cells using the TRIzol (Life Technologies) according to the manufacturer's instructions and was reverse-transcribed into cDNA using commercially available kits (Roche 11483188001). All subsequent quantitative qRT-PCR reactions were performed using the Applied Biosystems 7300 Real-Time system (Applied Biosystems) with the SYBR Green dye (Roche 04913850001). The threshold cycles (Ct-values) of all triplicates were normalized to 18S rRNA within each sample to obtain the sample-specific ΔCt values. To compare the effect of various treatments, ΔΔCt values were calculated. All other primers used are listed in Supporting Information Table S2.
We first searched the GWAS Central database (https://www.gwascentral.org) for association with BMI near/within the NPGPX (GPX7) gene using p-value threshold of 0.05 and 10kb-flanking region as search criteria. Three SNPs (rs835337, rs7529595, rs6588432) were identified in the British 1958 Birth Cohort study. These three SNPs were then analysed for replication in the North Finland 1966 Birth Cohort study and were further genotyped in Han Chinese replication sample.
The British 1958 cohort includes all births in England, Wales and Scotland, during one week in 1958. This cohort was originally recruited for a perinatal mortality and morbidity survey, and the participants were monitored throughout the school years with medical examinations. In this present study, blood samples were collected from 1424 cohort members at age 44–45. Genotyping was performed on Affymetrix GeneChip Mapping 500K, Custom Illumina Infinium and Illumina Infinium HumanHap550 genotyping platform. Detailed genotype information was retrieved from data deposited by Dr. Panos Deloukas (Wellcome Trust Sanger Institute).
The Northern Finland Birth Cohorts of 1966 (NFBC 1966) includes 12,058 live births to mothers in the two northern-most provinces of Finland. Follow-up of the NFBC 1966 with clinical data collection was performed at the age of 31 with assessment of a wide range of traits. DNA samples were obtained from 5923 subjects of NFBC1966. The GWAS was conducted in 4763 subjects using Illumina Human CNV370 v1 genotyping platform. A detailed description of the NFBC1966 GWAS can be found elsewhere (Sabatti et al, 2009). Detailed genotype and phenotype association analysis was requested from Dr. Freimer, Nelson B (University of California, LA).
Seven hundred and sixty Han Chinese subjects were recruited from a community-based screening program for the metabolic syndrome in Taiwan (Lin et al, 2009). Exclusion criteria were as follows: age<18 years, pregnant women, previously diagnosed diabetes or previously diagnosed major systemic diseases. Genomic DNA was extracted from peripheral blood leukocyte. Genotyping was performed using the Taqman platform (Life Technologies). Body weight, height and waist circumference was measured by trained nurse. Fasting plasma was collected after overnight fasting. Plasma malodialdehyde was measured by reaction with thiobarbituric acid (TBA) (Biovision K739-100). The Institutional Review Board of the National Taiwan University Hospital Research Ethics Committee approved this study. Written informed consent was obtained from each participant.
We recruited 84 female adults undergoing bariatric surgery or elective abdominal surgery such as cholecystectomy or partial hepatectomy from Ming-Sheng General Hospital in Taiwan. Abdominal subcutaneous fat depots were sampled in a fasting state during surgery and were placed in liquid nitrogen immediately until processing. The study was approved by the institutional review board of Ming-Sheng General Hospital and National Taiwan University Hospital. Written informed consent was obtained from each patient.
Independent Student's t-tests were used for comparisons between two independent groups. Paired t-tests were used to compare mRNA levels in fat pads from littermate mice pairs. The correlation between two groups was analysed using Pearson's correlation. The comparisons of body weight between two groups over time were analysed using repeated measure ANOVA. Non-parametric trend test for trend was used analysed the association of NPGPx gene expression levels across different genotypes. A Hardy–Weinberg equilibrium test was performed for each sequence variant before the marker-trait association analysis. The inter-marker LD was measured by pairwise D′ and r2 using the Haploview software (Barrett et al, 2005). Study-wide significance level taking into account of the LD between SNPs to keep a type 1 error of 5% for multiple testing was determined using the Nyholt's procedure (Nyholt, 2004). Linear regression in additive model was used to analyse the association between SNP and BMI in the British 1958 Birth Cohort and the Northern Finland Birth Cohorts of 1966. Linear regression in additive, recessive, and dominant models were used to analyse SNP association with BMI in the Han Chinese replication sample. The maximum tests were used to adjust p-value for multiple genetic models (So & Sham, 2011). Statistical analyses were conducted using SAS 9.0 and STATA 10.0. Meta-analysis was conducted using inverse-variance method for fixed effects implemented in the Comprehensive Meta-analysis (CMA) software. Cochran's Q and I square were used to measure the heterogeneity between studies. All p-values<0.05 were considered as statistically significant.
Obesity is serious global epidemic with huge health impact. Elevated oxidative stress is often observed in obese subjects and considered as a consequence of excessive fat accumulation. However, emerging evidence suggest that oxidative stress may contribute to adipogenesis. We have identified NPGPx as a sensor and transducer for oxidative stress signal and also found that NPGPx was mainly expressed in white adipose tissue. We ask whether NPGPx play an essential role in fat metabolism.
We found that deficiency of NPGPx raised ROS level in preadipocytes and promoted adipocyte differentiation via increasing oxidative stress. The increased oxidative stress causes conformational change of protein kinase A regulatory subunits, leading to activation of C/EBPβ, a critical transcriptional factors for adipogenesis. Consistently, NPGPx-deficient mice exhibited markedly increased fat mass and adipocyte hypertrophy. Treatment with antioxidant NAC ablated these phenotypes. Furthermore, genetic variation in human NPGPx gene correlated with lower NPGPx expression level in adipose tissues, were associated with higher body mass index in several independent human populations.
NPGPx is an important drug target as well as a biomarker for obesity. Patients carrying certain obesity-prone NPGPx genetic variant may benefit from antioxidant therapy.
YCC and YHY conducted experiments, analyzed data and wrote the manuscript. JYS coordinated all experiments and animal breeding and housing. WJL provided adipose tissue samples. JJH provided Han Chinese DNA samples and clinical data. YHC performed exercise endurance test. YRC performed lipidomics study. PCW provided plasmids. LMC and WHL designed the experiments, interpreted data and wrote the manuscript.
We acknowledge the use of genotype data from the British 1958 Birth Cohort DNA collection (funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02) and the genotype data from the Northern Finland Birth Cohort collection (funded by the NIH grant R01 HL087679). We thank Dr. Dale R. Nyholt (Queensland Institute of Medical Research) for the help of corrections for multiple correlated SNPs and Dr. Pi-Hua Liu (Chang-Gung University) for the statistical assistance of correction for multiple correlated genetic tests. We thank Dr. Eva Y.-H.P. Lee (University of California, Irvine) for critical comments of the manuscript. We also thank the Taiwan Mouse Clinic (funded by the National Research Program for Biopharmaceuticals of Taiwan) for their technical support, the National RNAi Core Facility for shRNA plasmid and the Metabolomics Core of Academia Sinica for targeted lipidomics study. This work was mainly supported by the Academia Sinica, Taiwan to WHL and in part by a grant (NSC 97–2314-B-002-047-MY3) from the National Science Council of Taiwan to LMC The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. YHY was supported by a postdoc fellowship and YCC by a fellowship for Translational Medicine Graduate Program from the Academia Sinica, Taiwan.
Supporting Information is available at EMBO Molecular Medicine online.
The authors declare that they have no conflict of interest.
Additional Supporting Information may be found in the online version of this article at the publisher's web-site:
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.